INSIGHTS ON DRUG DEVELOPMENT

• The Rise Of Complex OSD Generics: Understanding Development Challenges

  Understanding the potential pitfalls and partnering with the right experts can make all the difference in overcoming the complexities of complex generic OSD development.

• Integrating Phase-Appropriate Quality Standards

  Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.

• A Sensory Panel Study With The Focus On High-Intensity Sweeteners

  Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.

• Little Patients, Big Challenges: Developing Pediatric Formulations

  Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.

• Facts About AAV Producer Cell Lines

  8/8/2025

  Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.

• Using Residual DNA Quantification Data To De-Risk mAb Development

  6/11/2026

  Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

• Mechanical Engineering Design Process For Combination Products

  7/17/2026

  Mechanical engineering for combination drug-delivery devices demands more than good design — it requires data-driven risk management from specs through simulation. Learn how a structured phase approach ensures global manufacturing readiness.

• Advancing Multiomics Through Intelligent Automation

  10/27/2025

  Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.

• Dosage Form Scale-Up: Balancing Speed And Efficiency In Later-Stage Development

  9/22/2026

  Reduce development risk and improve readiness for larger trials with strategies that align formulation, manufacturing, and commercialization goals.